Your browser doesn't support javascript.
loading
Molecular interaction study of an anticancer drug, ponatinib with human serum albumin using spectroscopic and molecular docking methods.
Tayyab, Saad; Sam, Si Enn; Kabir, Md Zahirul; Ridzwan, Nor Farrah Wahidah; Mohamad, Saharuddin B.
Afiliação
  • Tayyab S; Biomolecular Research Group, Biochemistry Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia; Centre of Research for Computational Sciences and Informatics for Biology, Bioindustry, Environment, Agriculture and Healthcare, University of Mala
  • Sam SE; Biomolecular Research Group, Biochemistry Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.
  • Kabir MZ; Biomolecular Research Group, Biochemistry Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.
  • Ridzwan NFW; Bioinformatics Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.
  • Mohamad SB; Bioinformatics Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia; Centre of Research for Computational Sciences and Informatics for Biology, Bioindustry, Environment, Agriculture and Healthcare, University of Malaya, Kuala Lumpur, Malaysia.
Spectrochim Acta A Mol Biomol Spectrosc ; 214: 199-206, 2019 May 05.
Article em En | MEDLINE | ID: mdl-30780089

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Simulação de Acoplamento Molecular / Albumina Sérica Humana / Imidazóis / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Simulação de Acoplamento Molecular / Albumina Sérica Humana / Imidazóis / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article